Petco Health And Wellness Company, Inc. · NASDAQ:WOOF
Petco Health And Wellness — Q2 2026 Earnings Presentation
16 slides from Petco Health And Wellness's earnings presentation, Sep 2, 2026
Slide 1: Second Quarter 2026 Financial Highlights
Second Quarter 2026 Financial Highlights September 2, 2026
Slide 2: Safe Harbor and Non-GAAP Measures
Safe Harbor and Non-GAAP Measures This Presentation contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 as contained in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amend
Slide 3: Second Quarter 2026 Financial Highlights
Second Quarter 2026 Financial Highlights Exceeded Bottom Line Outlook in Q2 and Remain Committed to Strengthening Economic Model: Net sales increased 0.05%, with comparable sales growth of 0.6%—marking our second consecutive quarter of positive comparable sales growth. Results reflect stronger-t
Slide 4: Pivoting to Growth in 2026: Reach for the Sky
Pivoting to Growth in 2026: Reach for the Sky Reach for the Sky in 2026 is About Looking Up and Driving Forward Vision: leverage our differentiated omni-channel model to bolster competitive positioning, increase relevance and drive sales growth Offer Product Newness and Differentiation Innovate
Slide 5: We Continued to Make Progress within our Four Growth Pillars in Q2
We Continued to Make Progress within our Four Growth Pillars in Q2 Compelling Product Trusted Stores Experience Strength in cat contributed to growth in Sharing customer food purchasing data consumables with groomers to enhance cross shopping and customer engagement Continue to lead in fresh/f
Slide 6: Q2 2026 Net Sales & Comp
Q2 2026 Net Sales & Comp PERCENT OF SALES BY CATEGORY ($ in millions) Services & Q2'25 Services & Q2'26 Other Other 18% 18% $262.9 $272.4 Consumables Consumables $729.9 $731.3 49% 49% $485.6 $495.7 Supplies & Supplies & CA CA 33% 33% Q2’25 Q3’25 Q4’25 Q1’26 Q2’26 (2.3%) (3.1%) (2.4%) 0.2% 0.0% Reven
Slide 7: Q2 2026: Improving Profitability and Liquidity
Q2 2026: Improving Profitability and Liquidity OPERATING INCOME ADJUSTED EBITDA1 ($ in millions) ($ in millions) $113.9 $122.2 $43.0 $47.8 Q2'25 Q2'26 Q2'25 Q2'26 Operating Margin 2.9% 3.2% Adj. EBITDA Margin1 7.6% 8.2% NET DEBT1 & LIQUIDITY 2 FREE CASH FLOW1 ($ in millions) $129.9 Q2’25 Q2’26 YoY %
Slide 8: Reaffirming Full Year 2026 Outlook
Reaffirming Full Year 2026 Outlook Full Year 2026 Outlook Net Sales Flat to up 1.5% Adjusted EBITDA1 $415M to $430M Net Interest Expense ~$122M Capital Expenditures ~$140M Depreciation and ~$200M Amortization Net Store Closures 15 to 20 Full Year Outlook Considerations • Tariff Refunds: The outlook
Slide 9: Q3 2026 Outlook
Q3 2026 Outlook Q3 2026 Outlook Net Sales Up 0.4%-1.0% year over year Adjusted EBITDA 1 $100M to $103M Q3 Outlook Considerations • Tariff Refunds: Tariff refunds are substantially complete. The $6.8 million net tariff refund was recognized in Q2. • Assumes Flexibility to Invest: Given our solid prof
Slide 10: Non-GAAP Measures and Other Definitions
Non-GAAP Measure and Other Definitions
Slide 11: Non-GAAP Measures and Other Definitions
Non-GAAP Measures and Other Definitions The following information provides definitions and reconciliations of the non-GAAP financial measures presented in this Presentation to the most directly comparable financial measures calculated and presented in accordance with U.S. generally accepted accounti
Slide 12: Non-GAAP Measures: Adjusted EBITDA
Non-GAAP Measures: Adjusted EBITDA* (dollars in thousands) 13 Weeks Ended 26 Weeks Ended Reconciliation of Net Income Attributable to Class A and B-1 August 1, August 2, August 1, August 2, Common Stockholders to Adjusted EBITDA 2026 2025 2026 2025 Net income attributable to Class A and B-1 common s
Slide 13: Measures: Free Cash Flow
Non-GAAP Measures: Free Cash Flow *Change in free cash flow outflow driven by planned increases in capital expenditures and inventory investments 13
Slide 14: Measures: Net Debt
Non-GAAP Measures: Net Debt 14
Slide 15: Non-GAAP Financial Measures' Footnotes
Non-GAAP Financial Measures’ Footnotes (1) Mexico Joint Venture EBITDA represents 50 percent of the entity’s operating results for all periods, as adjusted to reflect the results on a basis comparable to Adjusted EBITDA. In the financial statements, this joint venture is accounted for as an equity m
Slide 16: ©2026 Petco Health and Wellness Company, Inc.
©2026 Petco Health and Wellness Company, Inc.
Petco Health and Wellness Company — Q2 2026 Earnings Presentation on 6ix